Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis: This cross-sectional analysis uses data from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey to determine whether chronic rhinosinusitis is associated with administration of antireflux medications.
Importance Antireflux medication has been endorsed as a useful adjunctive therapy for chronic rhinosinusitis, but its use remains controversial.
Objectives To determine whether chronic rhinosinusitis is associated with administration of proton pump inhibitors, histamine2-receptor antagonists, antacids, or prokinetic agents; whether practice patterns vary according to visit setting; and whether those patterns vary according to the presence or absence of potentially confounding conditions.
Design, Setting, and Participants A cross-sectional analysis was performed of data from January 1, 2005, to December 31, 2010, from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, which included 590 772 observations representing 7 191 711 480 ambulatory care visits. Univariate, multivariate, and stratified analyses were performed from January 1, 2005, to December 31, 2010.
Exposures Chronic rhinosinusitis.
Main Outcomes and Measures The probability of receiving antireflux medications was the main measured outcome.
Results Of 7 191 711 480 ambulatory care visits, those for chronic rhinosinusitis were not more likely to result in the administration of proton pump inhibitors (odds ratio, 1.00; 95% CI, 0.62-1.63; P = .99) or antacids and prokinetic agents (odds ratio, 1.24; 95% CI, 0.30-5.10; P = .77). In addition, patients with chronic rhinosinusitis were less likely to receive histamine2-receptor antagonists than were those without chronic rhinosinusitis, even when adjusted for age, sex, race/ethnicity, visit setting, other antireflux agents, and presence or absence of gastroesophageal reflux, laryngopharyngeal reflux, or allergy diagnoses (odds ratio, 0.25; 95% CI, 0.12-0.57; P = .001).
Conclusions and Relevance National practice patterns observed thus far have not favored the use of proton pump inhibitors, histamine2-receptor antagonists, antacids, or prokinetic agents for chronic rhinosinusitis.
http://ift.tt/2agz6Ts
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract We read with interest the recent paper by Felton and colleagues (1) describing the effects of solar-simulated ultraviolet radiati...
-
Publication date: Available online 8 April 2017 Source: European Journal of Vascular and Endovascular Surgery Author(s): M. Venermo, K. Ma...
-
AbstractBackground Early experience with transcatheter aortic valve replacement (TAVR) within failed bioprosthetic surgical aortic valves h...
-
New articles available on ScienceDirect New Articles in Press, 10 July Current evidence on DNA aneuploidy cytology in noninvasive detectio...
-
Related Articles Views of Japanese medical students on the work-life balance of female physicians. Int J Med Educ. 2017 May 11;8:165-...
-
Abstract Parkinson's disease (PD) is a progressive neurodegenerative disorder that is diagnosed largely on clinical grounds due to cha...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου